Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.960
+0.030 (1.02%)
Aug 11, 2025, 1:38 PM - Market open
Ligand Pharmaceuticals Market Cap
Lipocine has a market cap or net worth of $16.04 million as of August 11, 2025. Its market cap has decreased by -49.56% in one year.
Market Cap
16.04M
Enterprise Value
-1.81M
1-Year Change
-49.56%
Ranking
Category
Stock Price
$2.96
Market Cap Chart
Since October 22, 2013, Lipocine's market cap has decreased from $35.00M to $16.04M, a decrease of -54.17%. That is a compound annual growth rate of -6.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 15.90M | -39.08% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -26.21% |
| Dec 31, 2013 | 91.20M | 160.57% |
| Oct 22, 2013 | 35.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 569.12B |
| Johnson & Johnson | 417.99B |
| AbbVie | 352.18B |
| Abbott Laboratories | 233.88B |
| AstraZeneca | 227.78B |
| UnitedHealth Group | 225.81B |
| Novartis AG | 225.61B |
| Novo Nordisk | 213.92B |